sitc clinical practice guidelines on immune checkpoint inhibitor-related adverse events
Published 2 years ago • 84 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
1:35
sitc clinical practice guidelines on immune checkpoint inhibitor-related adverse events
-
7:50
the esc guidelines on cardio-oncology: incorporating the guidelines into clinical practice
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
1:08
incorporating checkpoint-inhibitors into second-line cll therapy
-
1:18
involving the patient in treatment decisions for cll
-
0:54
insights into the zuma-23 trial: axi-cel in frontline high-risk lbcl
-
10:42
surgical site infection (ssi) synopsis, including modifiable and non-modifiable risk factors
-
13:16
immune-related adverse events due to checkpoint inhibitors
-
11:15
chorioallantoic membrane (cam) assay: tools and techniques | jptv
-
1:25
the use of clonoseq to monitor mrd in patients with lbcl treated with axi-cel in zuma-7
-
3:47
the impact of cytogenetic-risk stratification on aml outcomes
-
1:50
outcomes of patients with dlbcl following asct and/or car-t
-
1:55
exploring first-line car-t therapy for the treatment of dlbcl
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo